These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3399507)

  • 1. Direct action of the parathyroid hormone-like human hypercalcemic factor on bone.
    Thompson DD; Seedor JG; Fisher JE; Rosenblatt M; Rodan GA
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5673-7. PubMed ID: 3399507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.
    McKee RL; Goldman ME; Caulfield MP; DeHaven PA; Levy JJ; Nutt RF; Rosenblatt M
    Endocrinology; 1988 Jun; 122(6):3008-10. PubMed ID: 2836181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor-secreted protein associated with human hypercalcemia of malignancy. Biology and molecular biology.
    Rosenblatt M; Caulfield MP; Fisher JE; Horiuchi N; Mckee RL; Rodan SB; Thiede MA; Thompson DD; Seedor JG; Nutt RE
    Ann N Y Acad Sci; 1988; 548():137-45. PubMed ID: 2854715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents.
    Yates AJ; Gutierrez GE; Smolens P; Travis PS; Katz MS; Aufdemorte TB; Boyce BF; Hymer TK; Poser JW; Mundy GR
    J Clin Invest; 1988 Mar; 81(3):932-8. PubMed ID: 3343349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivity of parathyroid hormone and parathyroid hormone-like peptide: agonist and antagonist activities of amino-terminal fragments as assessed by the cytochemical bioassay and in situ biochemistry.
    Loveridge N; Dean V; Goltzman D; Hendy GN
    Endocrinology; 1991 Apr; 128(4):1938-46. PubMed ID: 2004612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of continuous infusion of parathyroid hormone and parathyroid hormone-related peptide on rat bone in vivo: comparative study by histomorphometry.
    Kitazawa R; Imai Y; Fukase M; Fujita T
    Bone Miner; 1991 Mar; 12(3):157-66. PubMed ID: 2021707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic parathyroid hormone-like protein (1-74) is anabolic for bone in vivo.
    Weir EC; Terwilliger G; Sartori L; Insogna KL
    Calcif Tissue Int; 1992 Jul; 51(1):30-4. PubMed ID: 1393774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo.
    Sato K; Fujii Y; Kasono K; Ozawa M; Imamura H; Kanaji Y; Kurosawa H; Tsushima T; Shizume K
    Endocrinology; 1989 May; 124(5):2172-8. PubMed ID: 2539970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of postreceptor effects of 1-34 human hypercalcemia factor and 1-34 human parathyroid hormone in rat osteosarcoma cells.
    Rodan SB; Noda M; Wesolowski G; Rosenblatt M; Rodan GA
    J Clin Invest; 1988 Mar; 81(3):924-7. PubMed ID: 2830317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 7-34 analog of the parathyroid hormone-related protein has potent antagonist and partial agonist activity in vivo.
    Horiuchi N; Hongo T; Clemens TL
    Bone Miner; 1991 Mar; 12(3):181-8. PubMed ID: 1850633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
    Henderson J; Bernier S; D'Amour P; Goltzman D
    Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of parathyroid hormone and the synthetic 1-34 amino-terminal fragment in rats and dogs.
    Stevenson RW; Parsons JA
    J Endocrinol; 1983 Apr; 97(1):21-30. PubMed ID: 6842124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation in vivo of a potent parathyroid hormone antagonist: [Nle8,18,D-Trp12,Tyr34]bPTH(7-34)NH2.
    Dresner-Pollak R; Yang QM; Behar V; Nakamoto C; Chorev M; Rosenblatt M
    J Bone Miner Res; 1996 Aug; 11(8):1061-5. PubMed ID: 8854241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human parathyroid hormone (PTH)-related protein and human PTH: comparative biological activities on human bone cells and bone resorption.
    Fukayama S; Bosma TJ; Goad DL; Voelkel EF; Tashjian AH
    Endocrinology; 1988 Dec; 123(6):2841-8. PubMed ID: 2848688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone-related peptide increases urinary phosphate excretion in fetal lambs.
    Davicco MJ; Coxam V; Lefaivre J; Barlet JP
    Exp Physiol; 1992 Mar; 77(2):377-83. PubMed ID: 1581066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic adenosine monophosphate and bone gamma-carboxyglutamic acid-containing protein from perfused rat hindquarters.
    Calvo MS; Fryer MJ; Laakso KJ; Nissenson RA; Price PA; Murray TM; Heath H
    J Clin Invest; 1985 Dec; 76(6):2348-54. PubMed ID: 3001148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
    Fraher LJ; Hodsman AB; Jonas K; Saunders D; Rose CI; Henderson JE; Hendy GN; Goltzman D
    J Clin Endocrinol Metab; 1992 Aug; 75(2):417-23. PubMed ID: 1322424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies on an antagonist of parathyroid hormone [Nle-8, Nle-18, Tyr-34]bPTH-(3-34)amide.
    Gray DA; Parsons JA; Potts JT; Rosenblatt M; Stevenson RW
    Br J Pharmacol; 1982 Jun; 76(2):259-63. PubMed ID: 6284290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
    Tørring O; Turner RT; Carter WB; Firek AF; Jacobs CA; Heath H
    Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models.
    Azuma Y; Sato H; Oue Y; Okabe K; Ohta T; Tsuchimoto M; Kiyoki M
    Bone; 1995 Feb; 16(2):235-45. PubMed ID: 7756053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.